Novo Nordisk Partners with Valo Health to Develop Cardiometabolic Disease Therapies
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has announced a strategic partnership with US company...
Deals
Suzhou Novoprotein and Shanghai Model Organisms Center Ink Global Partnership
Suzhou Novoprotein Scientific Co., Ltd, (SHA: 688137) a leading provider of protein technology and application...
Chime Biologics Partners with Panolos Bioscience to Speed Up Multi-Specific Protein Development
China-based Contract Development and Manufacturing Organization (CDMO) Chime Biologics Ltd has announced a strategic cooperation...
Hangzhou Qihan Biotechnology Secures Over $13.8 Million in Pre-Series B Financing
Hangzhou Qihan Biotechnology Co., Ltd, a leading xenotransplantation specialist based in China, has reportedly raised...
Everest Medicines Partners with Kezar Life Sciences to Commercialize Zetomipzomib in Asia
Everest Medicines (HKG: 1952), a China-based pharmaceutical company, has announced a strategic collaboration and license...
I-Mab Regains Global Rights to CD47 Antibody Lemzoparlimab Following AbbVie Deal Termination
China-based biopharmaceutical company I-Mab (NASDAQ: IMAB) has received a notice from US-based AbbVie Global Enterprises...
Gurnet Point Capital and Novo Holdings Acquire Paratek Pharmaceuticals for $462 Million
Healthcare fund Gurnet Point Capital (GPC) and Novo Holdings, the controlling shareholder of Novo Nordisk...
Roche’s Genentech Partners with Orionis Biosciences for Molecular Glue Therapies
Genentech, a subsidiary of Swiss pharmaceutical giant Roche (SWX: ROG), has announced a partnership with...
Inmagene Biopharmaceuticals and Aditum Bio Launch JV Celexor Bio to Target Autoimmune Diseases
Inmagene Biopharmaceuticals, a China-based biopharmaceutical company, has announced a strategic collaboration with US firm Aditum...
Abbott Expands Biosimilars Portfolio with mAbxience In-License Agreement
Abbott (NYSE: ABT) has announced the in-licensing of several biosimilar drugs from Spain-based biotechnology firm...
Merck Forges Partnerships with BenevolentAI and Exscientia for Precision Drug Discovery
German pharmaceutical company Merck (NYSE: MRK) has announced two separate strategic collaborations with UK-based artificial...
Roche’s Genentech Partners with Peptidream for First-in-Class PDCs in Radioisotope Therapy
Swiss pharmaceutical giant Roche’s subsidiary, Genentech (SWX: ROG), has announced a partnership with Japan’s peptide-based...
Lynk Pharmaceuticals Secures Series C2 Financing to Advance pipeline
Lynk Pharmaceuticals Co., Ltd, a China-based pharmaceutical company, has announced the successful completion of its...
Eli Lilly Partners with Boundless Bio to Develop CHK1 Inhibitor for Solid Tumors
Eli Lilly (NYSE: LLY) has announced a partnership with precision oncology specialist Boundless Bio to...
Kangtai Biological Expands Global Reach with Varicella Vaccine Licensing Deals
Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601), a China-based biopharmaceutical company, has entered into...
Tianjin Century Kangtai Biomedical Raises Hundreds of Millions in Series A+ and B Financings
Tianjin Century Kangtai Biomedical Engineering Co., Ltd, a China-based company, has reportedly secured hundreds of...
Northeast Pharmaceutical Partners with Muscat Changming for Middle East Expansion
China-based Northeast Pharmaceutical Co., Ltd (SHE: 000597) has entered into an investment framework agreement with...
BRIM Biotechnology Raises $45.8 Million in Premium Share Issue for Pipeline Expansion
Taiwan-based BRIM Biotechnology, Inc. (TPEx 6885), a biotechnology company specializing in the development of regenerative...
Suzhou Acumen Biomedical Secures $13.8 Million in Series A+ Funding Round
China’s Suzhou Acumen Biomedical Technology Co., Ltd. has reportedly raised close to RMB 100 million...